These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32897133)

  • 1. Structural, Dosing, and Risk Change Factors Affecting Discontinuation of Pre-exposure Prophylaxis (PrEP) in a Large Urban Clinic.
    Shover CL; DeVost MA; Cunningham NJ; Beymer MR; Flores D; Flynn R; Gorbach PM; Lyman P; Amico KR; Bolan RK
    AIDS Educ Prev; 2020 Aug; 32(4):271-S13. PubMed ID: 32897133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Community perspectives on barriers and challenges to HIV pre-exposure prophylaxis access by men who have sex with men and female sex workers access in Nigeria.
    Emmanuel G; Folayan M; Undelikwe G; Ochonye B; Jayeoba T; Yusuf A; Aiwonodagbon B; Bilali C; Umoh P; Ojemeiri K; Kalaiwo A
    BMC Public Health; 2020 Jan; 20(1):69. PubMed ID: 31941469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
    Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
    PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Implications for PrEP Uptake in Young Adults Experiencing Homelessness: A Mixed Methods Study.
    Santa Maria D; Gallardo KR; Narendorf S; Petering R; Barman-Adhikari A; Flash C; Hsu HT; Shelton J; Ferguson K; Bender K
    AIDS Educ Prev; 2019 Feb; 31(1):63-81. PubMed ID: 30742477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mind the gaps: prescription coverage and HIV incidence among patients receiving pre-exposure prophylaxis from a large federally qualified health center in Los Angeles, California : Mind the Gaps: Cobertura de recetas e incidencia de VIH entre pacientes recibiendo profilaxis pre-exposición de un centro de salud grande y federalmente calificado en Los Ángeles, CA.
    Shover CL; Shoptaw S; Javanbakht M; Lee SJ; Bolan RK; Cunningham NJ; Beymer MR; DeVost MA; Gorbach PM
    AIDS Behav; 2019 Oct; 23(10):2730-2740. PubMed ID: 30953305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decentralizing the delivery of HIV pre-exposure prophylaxis (PrEP) through family physicians and sexual health clinic nurses: a dissemination and implementation study protocol.
    Sharma M; Chris A; Chan A; Knox DC; Wilton J; McEwen O; Mishra S; Grace D; Rogers T; Bayoumi AM; Maxwell J; Shahin R; Bogoch I; Gilbert M; Tan DHS
    BMC Health Serv Res; 2018 Jul; 18(1):513. PubMed ID: 29970087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reasons Why Young Men Who Have Sex with Men Report Not Using HIV Pre-Exposure Prophylaxis: Perceptions of Burden, Need, and Safety.
    Hess KM; Crawford J; Eanes A; Felner JK; Mittal ML; Smith LR; Hoenigl M; Amico KR
    AIDS Patient Care STDS; 2019 Oct; 33(10):449-454. PubMed ID: 31584856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unlocking HIV Pre-Exposure Prophylaxis Delivery: Examining the Role of HIV Providers in Pre-Exposure Prophylaxis Care.
    Kenison TC; Badenhop B; Safo S
    AIDS Patient Care STDS; 2020 Jun; 34(6):251-258. PubMed ID: 32484745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing uptake, continuation, and discontinuation of oral PrEP among clients at sex worker and MSM facilities in South Africa.
    Pillay D; Stankevitz K; Lanham M; Ridgeway K; Murire M; Briedenhann E; Jenkins S; Subedar H; Hoke T; Mullick S
    PLoS One; 2020; 15(4):e0228620. PubMed ID: 32352969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in Scotland.
    Young I; Flowers P; McDaid LM
    BMJ Open; 2014 Nov; 4(11):e005717. PubMed ID: 25412863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are PrEP services in France reaching all those exposed to HIV who want to take PrEP? MSM respondents who are eligible but not using PrEP (EMIS 2017).
    Annequin M; Villes V; Delabre RM; Alain T; Morel S; Michels D; Schmidt AJ; Velter A; Rojas Castro D
    AIDS Care; 2020 May; 32(sup2):47-56. PubMed ID: 32189518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV Pre-Exposure Prophylaxis and Women: Survey of the Knowledge, Attitudes, and Beliefs in an Urban Obstetrics/Gynecology Clinic.
    Koren DE; Nichols JS; Simoncini GM
    AIDS Patient Care STDS; 2018 Dec; 32(12):490-494. PubMed ID: 30036080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathways to HIV Pre-exposure Prophylaxis Among Women Prescribed PrEP at an Urban Sexual Health Clinic.
    Park CJ; Taylor TN; Gutierrez NR; Zingman BS; Blackstock OJ
    J Assoc Nurses AIDS Care; 2019; 30(3):321-329. PubMed ID: 30958408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Considering Stigma in the Provision of HIV Pre-Exposure Prophylaxis: Reflections from Current Prescribers.
    Calabrese SK; Tekeste M; Mayer KH; Magnus M; Krakower DS; Kershaw TS; Eldahan AI; Gaston Hawkins LA; Underhill K; Hansen NB; Betancourt JR; Dovidio JF
    AIDS Patient Care STDS; 2019 Feb; 33(2):79-88. PubMed ID: 30715918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measuring Acceptability and Preferences for Implementation of Pre-Exposure Prophylaxis (PrEP) Using Conjoint Analysis: An Application to Primary HIV Prevention Among High Risk Drug Users.
    Shrestha R; Karki P; Altice FL; Dubov O; Fraenkel L; Huedo-Medina T; Copenhaver M
    AIDS Behav; 2018 Apr; 22(4):1228-1238. PubMed ID: 28695388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Why Do HIV Pre-Exposure Prophylaxis Users Discontinue Pre-Exposure Prophylaxis Care? A Mixed Methods Survey in a Pre-Exposure Prophylaxis Clinic in Belgium.
    Vanbaelen T; Rotsaert A; Jacobs BKM; Florence E; Kenyon C; Vuylsteke B; Laga M; Thijs R
    AIDS Patient Care STDS; 2022 Apr; 36(4):159-167. PubMed ID: 35438524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Awareness, Yet Low Uptake, of Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women Within Family Planning Clinics in Kenya.
    Sila J; Larsen AM; Kinuthia J; Owiti G; Abuna F; Kohler PK; John-Stewart G; Pintye J
    AIDS Patient Care STDS; 2020 Aug; 34(8):336-343. PubMed ID: 32757980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Barriers and Facilitators to PrEP Initiation and Adherence Among Transgender and Gender Non-Binary Individuals in Southern California.
    Watson CW; Pasipanodya E; Savin MJ; Ellorin EE; Corado KC; Flynn RP; Opalo C; Lampley E; Henry BL; Blumenthal J; Bolan R; Morris S; Moore DJ
    AIDS Educ Prev; 2020 Dec; 32(6):472-485. PubMed ID: 33779208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Initiation, discontinuation, and restarting HIV pre-exposure prophylaxis: ongoing implementation strategies.
    Rutstein SE; Smith DK; Dalal S; Baggaley RC; Cohen MS
    Lancet HIV; 2020 Oct; 7(10):e721-e730. PubMed ID: 32861269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Location location location: an exploration of disparities in access to publicly listed pre-exposure prophylaxis clinics in the United States.
    Siegler AJ; Bratcher A; Weiss KM; Mouhanna F; Ahlschlager L; Sullivan PS
    Ann Epidemiol; 2018 Dec; 28(12):858-864. PubMed ID: 30406756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.